- Report
- November 2023
- 190 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- October 2023
- 186 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3499EUR$3,750USD£2,956GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2799EUR$3,000USD£2,364GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1400EUR$1,500USD£1,182GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1166EUR$1,250USD£985GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2799EUR$3,000USD£2,364GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2799EUR$3,000USD£2,364GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1400EUR$1,500USD£1,182GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1166EUR$1,250USD£985GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1400EUR$1,500USD£1,182GBP
- Clinical Trials
- January 2024
- 150 Pages
Global
From €2333EUR$2,500USD£1,970GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1400EUR$1,500USD£1,182GBP
- Report
- February 2024
- 200 Pages
Global
From €4432EUR$4,750USD£3,744GBP
- Report
- February 2024
- 111 Pages
Global
From €4432EUR$4,750USD£3,744GBP
- Report
- October 2023
- 190 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Report
- October 2023
- 178 Pages
Global
From €4572EUR$4,900USD£3,862GBP
- Clinical Trials
- June 2024
- 180 Pages
Global
From €2333EUR$2,500USD£1,970GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1400EUR$1,500USD£1,182GBP
- Clinical Trials
- April 2024
- 110 Pages
Global
From €1866EUR$2,000USD£1,576GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more